Silvana Konermann is a Swiss-American bioengineer and neuroscientist whose research focuses on CRISPR, genome engineering, transcription and epigenetics, and Alzheimer's disease.
She is an assistant professor of biochemistry at Stanford University, as well as co-founder and executive director of the Arc Institute in Palo Alto, California.
Konermann attended Sächsisches Landesgymnasium Sankt Afra zu Meißen in Saxony, Germany,[1] before matriculating in 2006 at ETH Zurich, where she completed her bachelor of science degree in neurobiology in three years.
She has also been a CZ Biohub Investigator and a postdoctoral fellow at the Salk Institute for Biological Studies and the University of California, Berkeley working with Patrick Hsu.
[2] Konermann's research uses genome engineering technologies to investigate the genetic and molecular drivers of Alzheimer’s disease risk.